Myriad Will Seek FDA Approval of BRACAnalysis CDx® As a Companion Diagnostic for Lynparza® (olaparib) In Men with Metastatic Castrate-Resistant Prostate Cancer

August 7, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search